benphothiamine has been researched along with Diabetic Angiopathies in 10 studies
benfotiamine : A thioester that is a synthetic analogue of thiamine obtained by acylative cleavage of the thiazole ring and O-phospohorylation.
Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, slower absorption and reduced bioavailability is a major limiting factor for its clinical use." | 2.58 | Therapeutic potential of benfotiamine and its molecular targets. ( Belur, PD; Howarth, FC; Ojha, S; Raj, V; Subramanya, SB, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raj, V | 1 |
| Ojha, S | 1 |
| Howarth, FC | 1 |
| Belur, PD | 1 |
| Subramanya, SB | 1 |
| Engelen, L | 1 |
| Stehouwer, CD | 1 |
| Schalkwijk, CG | 1 |
| Obrenovich, ME | 1 |
| Monnier, VM | 1 |
| Suzuki, S | 1 |
| Yamagishi, S | 1 |
| Imaizumi, T | 1 |
| Gadau, S | 1 |
| Emanueli, C | 1 |
| Van Linthout, S | 1 |
| Graiani, G | 1 |
| Todaro, M | 1 |
| Meloni, M | 1 |
| Campesi, I | 1 |
| Invernici, G | 1 |
| Spillmann, F | 1 |
| Ward, K | 1 |
| Madeddu, P | 1 |
| Małecka, SA | 1 |
| Poprawski, K | 1 |
| Bilski, B | 1 |
5 reviews available for benphothiamine and Diabetic Angiopathies
| Article | Year |
|---|---|
Therapeutic potential of benfotiamine and its molecular targets.
Topics: Animals; Diabetic Angiopathies; Humans; Signal Transduction; Thiamine | 2018 |
Current therapeutic interventions in the glycation pathway: evidence from clinical studies.
Topics: Animals; Atherosclerosis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathie | 2013 |
[Role of mitochondrial dysfunction in pathogenesis of diabetic microangiopathy].
Topics: Antioxidants; Coenzymes; Diabetic Angiopathies; DNA Damage; DNA, Mitochondrial; Drug Design; Electro | 2005 |
[Progress on the drug therapy for diabetic microangiopathies: AGE inhibitors].
Topics: Animals; Clinical Trials as Topic; Depression, Chemical; Diabetic Angiopathies; Glycation End Produc | 2005 |
[Prophylactic and therapeutic application of thiamine (vitamin B1)--a new point of view].
Topics: Animals; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus; Diabetic Angiopathies; Humans; Pai | 2006 |
5 other studies available for benphothiamine and Diabetic Angiopathies
| Article | Year |
|---|---|
[Diabetic neuropathies and angiopathies. Compensating for thiamine deficiency].
Topics: Adjuvants, Immunologic; Diabetic Angiopathies; Diabetic Neuropathies; Humans; Thiamine; Thiamine Def | 2010 |
[Prevention of complications in diabetes mellitus. Interdisciplinary collaboration to control sequelae].
Topics: Adjuvants, Immunologic; Animals; Cooperative Behavior; Cross-Sectional Studies; Diabetes Complicatio | 2011 |
Vitamin B1 blocks damage caused by hyperglycemia.
Topics: Aging; Animals; Cattle; Diabetic Angiopathies; Glucose Intolerance; Glycation End Products, Advanced | 2003 |
Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis.
Topics: Animals; Apoptosis; Blotting, Western; Body Weight; Caspase 3; Caspase Inhibitors; Caspases; Cell Pr | 2006 |
Benfotiamine. Monograph.
Topics: Alcoholic Neuropathy; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Humans; | 2006 |